Literature DB >> 23792117

A new tool to ensure the fluorescent dye labeling stability of nanocarriers: a real challenge for fluorescence imaging.

Guillaume Bastiat1, Christian Oliver Pritz, Clemens Roider, Florian Fouchet, Erwann Lignières, Alexander Jesacher, Rudolf Glueckert, Monika Ritsch-Marte, Anneliese Schrott-Fischer, Patrick Saulnier, Jean-Pierre Benoit.   

Abstract

Numerous studies on nanocarriers use fluorescent dye labeling to investigate their biodistribution or cellular trafficking. However, when the fluorescence dye is not grafted to the nanocarrier, the question of the stability of the labeling arises. How can it be validated that the fluorescence observed during an experiment corresponds to the nanocarriers, and not to the free dye released from the nanocarriers? Studying the integrity of the labeling is challenging. Therefore, an innovative approach to confirm the labeling stability was developed, based on the transfer of a fluorescent dye from its hosting nanocarrier to a lipophilic compartment. Lipid nanocapsules (LNC) and triglyceride oil were used as models. The protocol involved mixing of LNC suspension and oil, and then separation by centrifugation. The quality of the separation was controlled by light scattering, using the derived count rate tool. Dye transfer from loaded LNCs to the lipophilic compartment or from a lipophilic compartment containing dye to non-loaded LNC was investigated by varying the nature of the dye and the oil, the oil volume and the LNC dilution. Tensiometry was used to define the dye location in the nanocarrier. Results showed that when dyes such as Nile Red and Coumarin-6 are located in oily core, the transfer occurred in a partition-dependent manner. In contrast, when the dye was entrapped in the surfactant shell of LNCs such as lipophilic indocarbocyanines (i.e. DiO, DiI and DiD), no transfer was observed. Dye diffusion was also observed in cell culture, with Nile Red inside lipid bodies of HEI-OC1 cells, without uptake of LNCs. In contrast, DiO-loaded LNCs had to be internalized to observe fluorescence inside the cells, providing a further confirmation of the absence of transfer in this case, and the stability of fluorescence labeling of the LNCs.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell culture; Fluorescent dye; Labeling of nanocarrier; Light scattering; Lipid nanocapsule

Mesh:

Substances:

Year:  2013        PMID: 23792117     DOI: 10.1016/j.jconrel.2013.06.014

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  20 in total

1.  A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system.

Authors:  Rebecca L Cook; Kyle T Householder; Eugene P Chung; Alesia V Prakapenka; Danielle M DiPerna; Rachael W Sirianni
Journal:  J Control Release       Date:  2015-10-22       Impact factor: 9.776

2.  Delivery of a model lipophilic membrane cargo to bone marrow via cell-derived microparticles.

Authors:  Chunyan Yang; Fangfang Chen; Ping Ren; Laren Lofchy; Chun Wan; Jingshi Shen; Guankui Wang; Hanmant Gaikwad; Jessica Ponder; Craig T Jordan; Robert Scheinman; Dmitri Simberg
Journal:  J Control Release       Date:  2020-07-16       Impact factor: 9.776

3.  Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment.

Authors:  Liqiong Cai; Gaofei Xu; Changying Shi; Dandan Guo; Xu Wang; Juntao Luo
Journal:  Biomaterials       Date:  2014-10-31       Impact factor: 12.479

4.  Fine-tuning vitamin E-containing telodendrimers for efficient delivery of gambogic acid in colon cancer treatment.

Authors:  Wenzhe Huang; Xu Wang; Changying Shi; Dandan Guo; Gaofei Xu; Lili Wang; Alexa Bodman; Juntao Luo
Journal:  Mol Pharm       Date:  2015-03-02       Impact factor: 4.939

5.  Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis.

Authors:  Asmaa A Ashour; Amal H El-Kamel; Doaa A Abdelmonsif; Hoda M Khalifa; Alyaa A Ramadan
Journal:  Int J Nanomedicine       Date:  2021-12-08

6.  In vitro interaction of polyethylene glycol-block-poly(D,L-lactide) nanocapsule devices with host cardiomyoblasts and Trypanosoma cruzi-infective forms.

Authors:  Raoni Pais Siqueira; Matheus Marques Milagre; Maria Alice de Oliveira; Renata Tupinambá Branquinho; Fernanda Karoline Vieira Torchelsen; Marta de Lana; Marina Guimarães Carvalho Machado; Margareth Spangler Andrade; Maria Terezinha Bahia; Vanessa Carla Furtado Mosqueira
Journal:  Parasitol Res       Date:  2022-08-16       Impact factor: 2.383

7.  Functional-segregated coumarin-containing telodendrimer nanocarriers for efficient delivery of SN-38 for colon cancer treatment.

Authors:  Gaofei Xu; Changying Shi; Dandan Guo; Lili Wang; Yun Ling; Xiaobing Han; Juntao Luo
Journal:  Acta Biomater       Date:  2015-04-22       Impact factor: 8.947

8.  Nanoparticle mediated drug delivery of rolipram to tyrosine kinase B positive cells in the inner ear with targeting peptides and agonistic antibodies.

Authors:  Rudolf Glueckert; Christian O Pritz; Soumen Roy; Jozsef Dudas; Anneliese Schrott-Fischer
Journal:  Front Aging Neurosci       Date:  2015-05-19       Impact factor: 5.750

9.  Lipid Nanoparticles Vectorized with NFL-TBS.40-63 Peptide Target Oligodendrocytes and Promote Neurotrophin-3 Effects After Demyelination In Vitro.

Authors:  Catherine Fressinaud; Olivier Thomas; Anita Monika Umerska; Patrick Saulnier
Journal:  Neurochem Res       Date:  2020-09-10       Impact factor: 3.996

10.  Liposomal Extravasation and Accumulation in Tumors as Studied by Fluorescence Microscopy and Imaging Depend on the Fluorescent Label.

Authors:  Guankui Wang; Markella Zannikou; Laren Lofchy; Yue Li; Hanmant Gaikwad; Irina V Balyasnikova; Dmitri Simberg
Journal:  ACS Nano       Date:  2021-07-01       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.